A 4200-gm infant was born by normal vaginal delivery at term at an outside hospital. The newborn was healthy and was routinely discharged from the nursery. The child suddenly developed gross hematuria at 15 weeks of life. A renal sonogram ( Figure 1 ) was performed that demonstrated a cystic right renal mass and a normal left kidney. The child subsequently underwent a right nephrectomy.
There are two pathologic variants: classic CMN and atypical or cellular CMN. 4 Classic CMN is a histologically indolent tumor of monotypical spindle cells with low cellularity and no atypia. 5 Dilated vessels and entrapped nephrons are sometimes seen at the periphery of the tumor. 4 Perinephric fat infiltration occurs frequently, 5, 6 but vascular invasion does not. Atypical or cellular CMN is characterized by high cellularity, frequent mitoses, nuclear atypia, and areas of necrosis. 7 However, there is no convincing evidence that the prognosis of atypical tumors with dense cellularity, mitoses, and necrosis is significantly different from the classic variety. 5 Cystic mesoblastic nephroma is a variant of atypical or cellular mesoblastic nephroma that was first described in 1981. 8 Rarely CMN exhibits local recurrence and/or distant metastases develop. Of the 330 cases of CMN in Dr. Becroft's files, 5 7.3% have had local recurrence or metastases; a total of 1.8% of patients have died with persistent disease. The sites of metastases include the lung, heart, bone, and brain. 9 The ratio of classic to cellular tumors is 1:2 among patients with aggressive relapsing CMN and for patients with nonrelapsing tumors.
Pathologically, cysts are found in ϳ25% 10 of tumors. Cystic lesions sometimes show a pooling of contrast medium at the time of computed tomography or intravenous urography.
11 This is thought to be due to excretion into a cyst by functioning nephrons trapped within the tumor. 12, 13 The cell of origin of mesoblastic nephroma is not known, although the tumor usually contains predominantly myofibroblastic elements. 8 There is increasing evidence that CMN and Wilms' tumor have a common etiology. The prime evidence is the occasional association of mesoblastic nephroma with both nephrogenic rests and Beckwith-Wiedemann syndrome.
14 This has led to the hypothesis that a mesoblastic nephroma results from an induction of primitive blastema at a point when it is not metanephric but only stromagenic. 2, 8, 14, 15 The malignant clear cell sarcoma is believed to be the most aggressive end of the spectrum of this stromal tumor induction. 4 There is a significant difference in age of presentation between classic CMN and cellular CMN. The average age at presentation for classic CMN is 5 days of life; for cellular CMN, it is 5.3 months. 4 In fact, patient age is thought to be a relatively important prognostic factor. Both classic and cellular tumors have an excellent prognosis under the age of 3 months. 16 However, even age is not a reliable prognostic feature. Approximately one-third of CMNs that have relapsed have been found in patients of Ͻ3 months of age. 9 Patients with CMN usually present with a palpable flank mass (95%) and less often with hematuria (18%), 6 hypertension, anemia, jaundice, or vomiting. 6, 7 Sonographically classic CMN may appear as a hypoechogenic tumor with an echogenic rim (the so called ring sign) 4 or as a homogeneous or heterogeneous solid mass with no discernible rim. In the latter instance, differentiation from Wilms' tumor is not possible sonographically. However, age is an important diagnostic feature, because 75% of renal tumors in children of Ͻ3 months of age are CMN. In the case of cystic CMN, the differential diagnosis includes multilocular cystic nephroma, cystic partially differentiated nephroblastoma, Wilms' tumor with cyst formation, cystic renal cell carcinoma, and cystic clear cell sarcoma. 17 The treatment of patients with CMN of Ͻ3 months of age is nephrectomy alone with adequate margins to avoid leaving tumor in the perirenal fat. 6 Chemotherapy is indicated for patients with distant metastases, microscopic residual tumor, or tumor rupture. Recurrences or relapses are usually managed with a combination of surgery and chemotherapy. 1 Patients older than 3 months at the time of diag-www.nature.com/jp
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nosis are more likely to require chemotherapy. Sonography is usually the examination of choice to follow patients who have had nephrectomy for CMN.
